Fig. 3From: Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancerMutational correlates of the TICS. A The genetic alterations of patients in the TCGA cohorts. B–I Comparison of genetic features between the high- and low-TICS groups (MSI microsatellite instability, TMB tumor mutation burden, NtAI telomeric allelic imbalance, LST large-scale state transitions, LOH loss of heterozygosity, HRD homologous recombination deficiency, HR homologous recombination genes, MMR mismatch repair genes)Back to article page